Home
About
Overview
Sharing Data
ORCID
Help
History (3)
American Society for Surgery of the Hand – Young Member Leadership Program
Circadian and circannual timescales interact to generate seasonal changes in immune function.
Efficacy of biosimilar infliximab CT-P13 among inpatients with severe steroid-refractory colitis.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Efficacy of biosimilar infliximab CT-P13 among inpatients with severe steroid-refractory colitis.
Efficacy of biosimilar infliximab CT-P13 among inpatients with severe steroid-refractory colitis. Int J Colorectal Dis. 2020 Nov; 35(11):2113-2116.
View in:
PubMed
subject areas
Adult
Antibodies, Monoclonal
Biosimilar Pharmaceuticals
Colitis, Ulcerative
Gastrointestinal Agents
Humans
Infliximab
Inpatients
Retrospective Studies
Steroids
Treatment Outcome
authors with profiles
Sushila R. Dalal
Dejan Micic
David T. Rubin
Joel R. Pekow
Russell D. Cohen